T. Donohue

发表

Increased risk of bone loss without fracture risk in long-term survivors after allogeneic stem cell transplantation.

A. Barrett, R. Childs, B. Savani, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Improved survival in steroid‐refractory acute graft versus host disease after non‐myeloablative allogeneic transplantation using a daclizumab‐based strategy with comprehensive infection prophylaxis

N. Geller, R. Srinivasan, A. Barrett, 2004, British journal of haematology.

Neuroradiology Manifestations of Li-Fraumeni Syndrome: Epidemiology, Genetics, Imaging Findings, and Management

A. Srinivasan, T. Moritani, Y. Ota, 2020 .

The Level of Minimal Residual Disease in Primitive Progenitor Cells from CML Patients after Allogeneic Stem Cell Transplantation Is Higher Than after Treatment with Tyrosine Kinase Inhibitors.

K. Rezvani, K. Keyvanfar, A. Barrett, 2008 .

Engraftment syndrome after nonmyeloablative allogeneic hematopoietic stem cell transplantation: incidence and effects on survival.

N. Geller, R. Srinivasan, A. Barrett, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Adoptive Transfer of Escalating Doses of Ex Vivo Expanded Autologous Natural Killer (NK) Cells In Patients with Advanced Malignancies Following Bortezomib Treatment to Sensitize to NK-TRAIL Cytotoxicity

K. Keyvanfar, D. Stroncek, M. Berg, 2010 .

Long-term outcome of fludarabine-based reduced-intensity allogeneic hematopoietic cell transplantation for debilitating paroxysmal nocturnal hemoglobinuria.

N. Geller, N. Young, P. Scheinberg, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Rapid donor T‐cell engraftment increases the risk of chronic graft‐versus‐host disease following salvage allogeneic peripheral blood hematopoietic cell transplantation for bone marrow failure syndromes

N. Geller, N. Young, D. Stroncek, 2013, American journal of hematology.

Reduced Incidence of Acute Graft Versus Host Disease (GVHD) and Transplant-Related Mortality (TRM) with the Addition of Short-Course Mini-Dose Methotrexate (MTX) to Cyclosporine (CSA) as GVHD Prophylaxis Following Nonmyeloablative Hematopoietic Stem Cell Transplantation (NST).

N. Geller, H. Hedlin, R. Srinivasan, 2007 .

Long-term persistence of nonpathogenic clonal chromosome abnormalities in donor hematopoietic cells after allogeneic stem cell transplantation.

R. Srinivasan, R. Childs, A. Meloni-Ehrig, 2009, Cancer genetics and cytogenetics.

Evaluation of Three Different Cyclosporine-Based Graft Versus Host Disease (GVHD) Prophylaxis Regimens Following Nonmyeloablative Hematopoietic Stem Cell Transplantation (NST).

N. Geller, R. Srinivasan, R. Childs, 2004 .

Short communication Long-term persistence of nonpathogenic clonal chromosome abnormalities in donor hematopoietic cells after allogeneic stem cell transplantation

R. Srinivasan, R. Childs, A. Meloni-Ehrig, 2009 .

Successful Use of Balloon Ablation to Treat Menorrhagia Complicating Aplastic Anemia

E. Sloand, P. Stratton, T. Donohue, 2008, Gynecologic and Obstetric Investigation.

Chronic GVHD manifesting as parotitis after allogeneic hematopoietic SCT

N. Patronas, R. Childs, M. Ramanathan, 2009, Bone Marrow Transplantation.